Amelioration of rotenone-induced Parkinson's disease; comparing therapeutic role of erythropoietin versus low-level laser activation of mesenchymal stem cells (an in-vivo and in-vitro study)

Amelioration of rotenone-induced Parkinson's disease; comparing therapeutic role of erythropoietin versus low-level laser activation of mesenchymal stem cells (an in-vivo and in-vitro study)

ABSTRACTParkinson's disease (PD), the second common neurodegenerative disease, is characterized by the loss of the dopaminergic neurons in the substantia nigra (SN). Because of L-dopa's side effects, new therapeutic methods were considered such as stem cells for PD treatment. The major cha...

Full description

Bibliographic Details
Main Authors: Eman Mumtaz El Mahdy, Maha Gamal, Basma Emad Aboulhoda, Basent Adel Al Dreny, Ashraf Shamaa, Laila Rashed, Ahmed Nour Eldine Abdallah, Asmaa M. Shamseldeen
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Animal Cells and Systems
Subjects:
Parkinson’s disease
low-level laser therapy
erythropoietin
MSCs
Mir-155
Online Access:https://www.tandfonline.com/doi/10.1080/19768354.2023.2273467

Internet

https://www.tandfonline.com/doi/10.1080/19768354.2023.2273467

Similar Items